We can speculate that this may be the underlying mechanism in DBA because DBA erythroid precursors treated by rapamycin, an mTOR inhibitor, have been shown to increase the proliferation of late erythroid cells in DBA [86]. Here, MTOR is linked to Diamond-Blackfan anemia.